BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a
Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma
✍ Scribed by Carsten G. Häckel; Sabine Krueger; Hans-Jürgen Grote; Yumi Oshiro; Sherie Hodges; Dennis A. Johnston; Mark E. Johnson; Albert Roessner; Alberto G. Ayala; Bogdan Czerniak
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 282 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
defined risk factor in patients with gastric carcinoma. ## METHODS. Enzyme-linked immunoadsorbent assays were used to test for uPA anti-
During B- and T-cell ontogeny, extensive apoptosis occurs at distinct stages of development. Agents that increase intracellular levels of cAMP induce apoptosis in thymocytes and mature B cells, prompting us to investigate the role of cAMP signaling in human CD10+ B-precursor cells. We show for the f